🇺🇸 FDA
Patent

US 10927089

Diaryl thioether piperazine compounds, preparation methods and uses thereof

granted A61KA61K31/495A61K45/06

Quick answer

US patent 10927089 (Diaryl thioether piperazine compounds, preparation methods and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/495, A61K45/06, A61P, A61P25/24